Covishield marketing authorisation will be considered when application is received: EU agency Ruchika Sharma29 Jun 2021 5:03 PM ISTNew Delhi: The Covishield vaccine "does not currently have a marketing authorisation" in Europe and the matter would be considered when an application...
EU regulator identifies another rare blood condition as side effect of AstraZeneca shot Ruchika Sharma12 Jun 2021 10:00 AM ISTNew Delhi: Europe's drug regulator on Friday identified another very rare blood condition as a potential side effect of AstraZeneca's Covid-19 vaccine...
AstraZeneca COVID vaccine linked blood clot case reported in South Korea Medical Dialogues Team31 May 2021 9:45 AM ISTAround 3.27 million people in South Korea have received at least one dose of the AstraZeneca vaccine so far.
Sun pharma secures trademarks rights of diabetes drug Dapagliflozin under 3 brands from AstraZeneca Ruchika Sharma29 May 2021 5:30 PM ISTNew Delhi: Drug major Sun Pharma on Friday said it has acquired the rights to trademarks of diabetes drug Dapagliflozin under brands Oxra, Oxramet and...
Unichem Labs gets USFDA nod for Amitriptyline HCl Tablets Ruchika Sharma21 May 2021 12:26 PM ISTMumbai: Drugmajor, Unichem Laboratories Limited, has recently announced that the company has received ANDA approval for its Amitriptyline HCl Tablets...
Delhi HC asks NPPA to reconsider show cause issued to AstraZeneca over cancer drug Tagrisso Medical Dialogues Team16 May 2021 11:00 AM ISTNew Delhi: The National Pharmaceutical Pricing Authority (NPPA) has been directed by the Delhi High Court to reconsider and issue a fresh order to...
Covishield doses meant for UK export to be used in India Ruchika Sharma8 May 2021 4:40 PM IST"The stock of 50 lakh doses of Covishield vaccine is now available for inoculation of 18-44 age group people in 21 states and UTs," an official source...
AstraZeneca Farxiga gets approval in US for CKD prevention Ruchika Sharma2 May 2021 9:30 AM ISTUK: AstraZeneca's Farxiga (dapagliflozin), a sodium-glucose cotransporter 2 (SGLT2) inhibitor, has been approved in the US to reduce the risk of...
Serum Institute plans to start COVID vaccine production outside India: Report Ruchika Sharma1 May 2021 3:38 PM ISTNew Delhi: The Serum Institute of India, which manufactures the AstraZeneca Covid-19 vaccine, is planning to start vaccine production in other...
COVID-19: India likely to get US supplies of AstraZeneca vaccine in few weeks Ruchika Sharma29 April 2021 9:00 AM ISTNew York: The US is "looking at options" to ship millions of AstraZeneca vaccines to India but that can happen only after it clears federal safety...
Per dose of Covishield to cost Rs 400 for states, Rs 600 for private hospitals: Serum Institute Ruchika Sharma22 April 2021 12:00 PM ISTNew Delhi: Serum Institute of India''s Covishield vaccine will cost private hospitals Rs 600 per dose and state governments Rs 400, a rate which will...
Covid-19: Africa Centres for Disease Control and Prevention urges India to lift vaccine export limits Ruchika Sharma18 April 2021 10:15 AM ISTNew Delhi: Africa's top health official said Thursday he wants to believe that India will lift export restrictions on Covid-19 vaccines as soon as...
